| |
| |
|
| Insider
Information: |
Collins Cooper C. |
| Relationship: |
Director |
| City: |
Magnolia |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,546,768 |
|
|
Indirect Shares
|
1,026,525 |
|
|
| Direct
Value |
$153,236 |
|
|
|
Indirect Value
|
$21,865 |
|
|
| Total
Shares |
3,573,293 |
|
|
| Total
Value |
$175,101 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
4
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -45.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pernix Therapeutics Holdings |
PTX |
Chief Strategic Officer |
2014-04-02 |
2,500,046 |
2014-04-02 |
1,026,525 |
Premium* |
|
|
Therapeuticsmd Inc |
TXMD |
Director |
2022-08-18 |
46,722 |
2013-06-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2012-02-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,631,579 |
|
- |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2013-06-14 |
4 |
S |
$1.75 |
$4,605,263 |
I/I |
(2,631,579) |
0 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2014-06-05 |
4 |
B |
$3.84 |
$76,890 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2016-03-11 |
4 |
B |
$6.23 |
$99,717 |
D/D |
16,000 |
36,000 |
2.39 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2020-06-08 |
4 |
B |
$1.45 |
$38,425 |
D/D |
26,500 |
92,500 |
2.39 |
% |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2020-06-09 |
4 |
B |
$1.45 |
$68,875 |
D/D |
47,500 |
140,000 |
2.39 |
% |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2021-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,864 |
236,864 |
0 |
- |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2021-08-17 |
4 |
B |
$0.77 |
$77,000 |
D/D |
100,000 |
336,864 |
2.39 |
% |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2021-08-18 |
4 |
B |
$0.72 |
$648,000 |
D/D |
900,000 |
1,236,864 |
2.39 |
% |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2021-11-18 |
4 |
B |
$0.58 |
$578,500 |
D/D |
1,000,000 |
2,236,864 |
2.39 |
% |
|
| TXMD |
Therapeuticsmd Inc |
Director |
– • – |
2022-08-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,984 |
46,722 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
President and CEO |
• • • |
2010-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
9,405,000 |
9,405,000 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
President and CEO |
• • • |
2011-07-21 |
4 |
S |
$7.00 |
$3,489,003 |
D/D |
(498,429) |
8,906,571 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
President and CEO |
• • • |
2011-08-11 |
5 |
GD |
$0.00 |
$0 |
D/D |
635,844 |
7,634,883 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
President and CEO |
• • • |
2012-09-17 |
5 |
GA |
$0.00 |
$0 |
I/I |
245,163 |
245,163 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
President and CEO |
• • • |
2012-09-17 |
5 |
GD |
$0.00 |
$0 |
I/I |
245,163 |
390,681 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
Chief Strategic Officer |
• • • |
2013-07-24 |
4 |
D |
$4.04 |
$5,050,000 |
D/D |
(1,250,000) |
6,630,046 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
Chief Strategic Officer |
• • • |
2013-10-01 |
4 |
AS |
$2.61 |
$72,516 |
D/D |
(27,736) |
6,602,310 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
Chief Strategic Officer |
• • • |
2013-10-02 |
4 |
AS |
$2.57 |
$33,909 |
D/D |
(13,200) |
6,589,110 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
Chief Strategic Officer |
• • • |
2013-10-03 |
4 |
AS |
$2.46 |
$63,312 |
D/D |
(25,700) |
6,563,410 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
Chief Strategic Officer |
• • • |
2013-10-04 |
4 |
AS |
$2.45 |
$26,443 |
D/D |
(10,785) |
6,552,625 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
Chief Strategic Officer |
• • • |
2013-10-07 |
4 |
AS |
$2.49 |
$30,780 |
D/D |
(12,379) |
6,540,246 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
Chief Strategic Officer |
• • • |
2013-10-08 |
4 |
AS |
$2.51 |
$502 |
D/D |
(200) |
6,540,046 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
Chief Strategic Officer |
• • • |
2013-11-01 |
4 |
AS |
$2.01 |
$89,732 |
D/D |
(44,561) |
6,495,485 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
Chief Strategic Officer |
• • • |
2013-11-04 |
4 |
AS |
$2.01 |
$30,620 |
D/D |
(15,200) |
6,480,285 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
